Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty

We developed a computerized clinical decision support system (CCDSS) for venous thromboembolism (VTE) risk assessment. We aimed to demonstrate its relevance and evaluate associations between risk level and VTE incidence in patients undergoing total hip/knee arthroplasty. In this case-control study,...

Full description

Bibliographic Details
Main Authors: Akihiko Akamine MSc, Naonobu Takahira PhD, Masayuki Kuroiwa PhD, Atsushi Tomizawa MSc, Koichiro Atsuda PhD
Format: Article
Language:English
Published: SAGE Publishing 2022-05-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296221103868
_version_ 1811239654916096000
author Akihiko Akamine MSc
Naonobu Takahira PhD
Masayuki Kuroiwa PhD
Atsushi Tomizawa MSc
Koichiro Atsuda PhD
author_facet Akihiko Akamine MSc
Naonobu Takahira PhD
Masayuki Kuroiwa PhD
Atsushi Tomizawa MSc
Koichiro Atsuda PhD
author_sort Akihiko Akamine MSc
collection DOAJ
description We developed a computerized clinical decision support system (CCDSS) for venous thromboembolism (VTE) risk assessment. We aimed to demonstrate its relevance and evaluate associations between risk level and VTE incidence in patients undergoing total hip/knee arthroplasty. In this case-control study, VTE was confirmed using ultrasonography/computed tomography angiography in 1098 adults at a tertiary care hospital over five years (2013-2018). Postoperative VTE incidence was classified into three risk levels (moderate, high, and highest). The overall VTE incidence was 11.7%, which increased with a risk level of 0%, 5.8%, and 12.8% in moderate-risk, high-risk, and highest-risk patients, respectively. Highest-risk patients were significantly more likely to develop VTE than high-risk patients (odds ratio [OR] 2.4; 95% confidence interval [CI] 1.2-5.5; p = 0.01). VTE development was more likely in patients with risk scores ≥4 relative to those with risk scores of 2–3 (OR 1.8; 95% CI 1.2-2.7; p = 0.003) and −1 to 1 (OR 3.3; 95% CI 1.6-7.7; p < 0.001). This study indicates that risk level and VTE incidence are associated; our scoring system appears useful for patients undergoing total hip/knee arthroplasty.
first_indexed 2024-04-12T13:03:46Z
format Article
id doaj.art-a15106c6221244e5a2e7f3bd065acddf
institution Directory Open Access Journal
issn 1938-2723
language English
last_indexed 2024-04-12T13:03:46Z
publishDate 2022-05-01
publisher SAGE Publishing
record_format Article
series Clinical and Applied Thrombosis/Hemostasis
spelling doaj.art-a15106c6221244e5a2e7f3bd065acddf2022-12-22T03:32:05ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232022-05-012810.1177/10760296221103868Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee ArthroplastyAkihiko Akamine MSc0Naonobu Takahira PhD1Masayuki Kuroiwa PhD2Atsushi Tomizawa MSc3Koichiro Atsuda PhD4 Department of Pharmacy, , Sagamihara, Kanagawa, Japan Physical Therapy Course, Department of Rehabilitation, , Sagamihara, Kanagawa, Japan Department of Anesthesiology, , Sagamihara, Kanagawa 252-0373, Japan Department of Pharmacy, , Sagamihara, Kanagawa, Japan Research and Education Center for Clinical Pharmacy, Division of Clinical Pharmacy, Laboratory of Pharmacy Practice and Science 1, , Minato-ku, Tokyo, JapanWe developed a computerized clinical decision support system (CCDSS) for venous thromboembolism (VTE) risk assessment. We aimed to demonstrate its relevance and evaluate associations between risk level and VTE incidence in patients undergoing total hip/knee arthroplasty. In this case-control study, VTE was confirmed using ultrasonography/computed tomography angiography in 1098 adults at a tertiary care hospital over five years (2013-2018). Postoperative VTE incidence was classified into three risk levels (moderate, high, and highest). The overall VTE incidence was 11.7%, which increased with a risk level of 0%, 5.8%, and 12.8% in moderate-risk, high-risk, and highest-risk patients, respectively. Highest-risk patients were significantly more likely to develop VTE than high-risk patients (odds ratio [OR] 2.4; 95% confidence interval [CI] 1.2-5.5; p = 0.01). VTE development was more likely in patients with risk scores ≥4 relative to those with risk scores of 2–3 (OR 1.8; 95% CI 1.2-2.7; p = 0.003) and −1 to 1 (OR 3.3; 95% CI 1.6-7.7; p < 0.001). This study indicates that risk level and VTE incidence are associated; our scoring system appears useful for patients undergoing total hip/knee arthroplasty.https://doi.org/10.1177/10760296221103868
spellingShingle Akihiko Akamine MSc
Naonobu Takahira PhD
Masayuki Kuroiwa PhD
Atsushi Tomizawa MSc
Koichiro Atsuda PhD
Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
Clinical and Applied Thrombosis/Hemostasis
title Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
title_full Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
title_fullStr Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
title_full_unstemmed Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
title_short Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
title_sort internal validation of a risk scoring system for venous thromboembolism after total hip or knee arthroplasty
url https://doi.org/10.1177/10760296221103868
work_keys_str_mv AT akihikoakaminemsc internalvalidationofariskscoringsystemforvenousthromboembolismaftertotalhiporkneearthroplasty
AT naonobutakahiraphd internalvalidationofariskscoringsystemforvenousthromboembolismaftertotalhiporkneearthroplasty
AT masayukikuroiwaphd internalvalidationofariskscoringsystemforvenousthromboembolismaftertotalhiporkneearthroplasty
AT atsushitomizawamsc internalvalidationofariskscoringsystemforvenousthromboembolismaftertotalhiporkneearthroplasty
AT koichiroatsudaphd internalvalidationofariskscoringsystemforvenousthromboembolismaftertotalhiporkneearthroplasty